Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions

Core Viewpoint - Roquette has announced a new organizational structure following the acquisition of IFF Pharma Solutions, aimed at enhancing agility and customer responsiveness for sustainable growth [1][4]. Group 1: Organizational Changes - The company has launched two renewed Business Groups: Health & Pharma Solutions and Nutrition & Bioindustry, each with dedicated teams and assets [3][5]. - Isabelle Bouvier has been appointed as CEO of the Health & Pharma Solutions Business Group, while Pascal Leroy will lead the Nutrition & Bioindustry Business Group [3][9]. - Béatrice Totel has been appointed as CFO of Roquette, succeeding Isabelle Bouvier [11][12]. Group 2: Business Group Focus - The Health & Pharma Solutions Business Group will focus on pharmaceutical excipients, enhancing customer service and product development agility [5][7]. - The Nutrition & Bioindustry Business Group will integrate product lines from IFF, enhancing expertise in food and industrial applications, positioning for growth in food, nutrition, and bio-based markets [8][10]. Group 3: Company Overview - Roquette employs over 11,000 people and operates more than 40 manufacturing sites and 20 R&D centers globally, achieving a turnover of €4.5 billion in 2024 [2][13]. - The company specializes in plant-based ingredients and pharmaceutical solutions, committed to innovation and sustainability [14].